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Abstract
Background: Poor sleep quality has been associated with increased risk of heart disease, diabetes
and mortality. However, limited information exists on the distribution and determinants of sleep
quality and its associations with cardio-metabolic risk factors in Chinese populations. We aimed to
evaluate this in the current study.
Methods: A cross-sectional survey conducted in 2005 of 1,458 men and 1,831 women aged 50–
70 years from urban and rural areas of Beijing and Shanghai. Using a questionnaire, sleep quality was
measured in levels of well, common and poor. Comprehensive measures of socio-demographical
and health factors and biomarkers of cardio-metabolic disease were recorded. These were
evaluated in association with sleep quality using logistic regression models.
Results: Half of the population reported good sleep quality. After adjusting for potential
confounders, women and Beijing residents had almost half the probability to report good sleep
quality. Good physical and mental health (good levels of self-rated health (OR 2.48; 95%CI 2.08 to
2.96) and no depression (OR 4.05; 95%CI 3.12 to 5.26)) related to an increased chance of reporting
good sleep quality, whereas short sleep duration (<7 hrs OR 0.10; 95%CI 0.07 to 0.14)) decreased
it substantially. There were significant associations between levels of sleep quality and
concentrations of plasma insulin, total and LDL cholesterol, and index of insulin resistance.
Conclusion: Levels of good sleep quality in middle-age and elderly Chinese were low. Gender,
geographical location, self-rated health, depression and sleep quantity were major factors
associated with sleep quality. Prospective studies are required to distil the factors that determine
sleep quality and the effects that sleep patterns exert on cardio-metabolic health.
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Sleep disturbances, including chronic insomnia (difficulty
in maintaining sleep, having intermittent awakening and
early awakening) and sleep apnea are increasingly com-
mon in modern societies with reported prevalences vary-
ing between 4 and 22 percent in different populations.[1]
Sleep disturbances are common in later life, with loss of
nocturnal sleep continuity and depth. [2-4] This could be
due to the high prevalence of diseases accompanied by
pain and stress, the side effects of taking medications and
the inherent changes in sleep architecture that tend to
occur with age. Aside from age and gender, physical and
mental health problems are reported to be significantly
associated with sleep disturbances. [5-8] Across different
populations, several studies have found a significant dele-
terious effect of sleep disturbances on self-rated health,
incidence of cardio-metabolic diseases (coronary heart
disease, metabolic syndrome and type 2 diabetes), quality
of life and mortality. [9-25] Various mechanisms have
been explored and suggested as the potential link between
poor sleep patterns and negative health outcomes (e.g.
impaired glucose regulation and subsequent increased
risk of type 2 diabetes[24]). Nevertheless the existing
information is limited and the pathophysiological path-
ways between poor sleep patterns and cardio-metabolic
disease remain unclear. Furthermore, although ample
data exist for different populations, there is limited infor-
mation on the levels of sleep disturbances among Chinese
populations, the possible factors associated and the
potential association of sleep quantity and quality with
biomarkers of early cardio-metabolic disorders.
Therefore, in order to evaluate the levels of sleep patterns
in Chinese and contribute to complement its related gap
of epidemiological evidence and knowledge, in the cur-
rent study we aimed to evaluate: (i) the distribution of
sleep quality; (ii) factors that determine sleep quality; and
(iii) whether self-reported sleep quality is associated with
biomarkers of cardio-metabolic disease in middle-aged
and elderly Chinese.
Methods
Study population
We used data from "Nutrition and Health of Aging Popu-
lation in China" study. [26-28] This is a cross-sectional
survey conducted between March and June 2005, among
3289 subjects (1,458 men and 1,831 women) aged 50 to
70 years from urban and rural areas of Beijing and Shang-
hai (metropolitan cities of north and south of China). The
sampling was conducted with an emphasis on recruiting
at least 40% of men, a similar number of rural/urban res-
idents of Beijing and Shanghai and a representation of
people from all levels of education and income. Trained
physicians or public health workers completed the sam-
pling through a face-to-face interview using a standard-
ized questionnaire to collect socio-demographical,
lifestyle and health related information. Further details
about the questionnaire can be found elsewhere.[29]
The study protocol was approved by the Institutional
Review Board of the Institute for Nutritional Sciences. All
participants provided written informed consents.
Assessment of sleep and related factors
Subjective sleep quality during the last month was
recorded in 3 levels (well, common or poor). Sleep quan-
tity was measured as self-reported average total hours of
daily sleep during the last month, including both night
and nap hours sleep and was categorized as under, normal
and over (<7, 7 to 9 and >9 hours per day respectively).
Socio-demographic variables included age (50–59 and
60–70 yrs), gender, geographic region (Beijing or Shang-
hai), residence of living (urban or rural), educational
attainment (low, moderate and high, based on the
number of years of education as 0 to 6, 7 to 9, and ≥10
years respectively), total household income (low, moder-
ate and high on the basis of less than 10,000, 10,000 to
29,999 and more than 30,000 Yuan annually), marital
status (married or without spouse), employment status
(grouped as currently employed, unemployed/on welfare
system and retired) and social activity ('yes' or 'no' on the
basis of participating in at least one of a list of social activ-
ities such as painting, playing chess, singing and dancing).
Lifestyle variables included smoking habit, defined as
never, current and former (cessation of smoking >6
months); alcohol drinking (grouped into "yes "or "no")
and physical activity level (low, moderate, or high)
according to the IPAQ (International Physical Activity
Questionnaire).
Self rated health (SRH) was initially recorded in 5 levels
(very good, good, fair, poor and very poor) and then com-
bined into two categories: good (very good and good) and
poor (fair, poor and very poor).[30,31] Pulmonary dis-
ease was defined as existence of at least one of the follow-
ing: asthma, chronic bronchitis, emphysema or chronic
cor-pulmonale diseases. Presence of diabetes was defined
as either measured fasting glucose greater than 7.0 mmol/
L or being diagnosed with type 2 diabetes or taking anti-
diabetes drugs or insulin. Presence of cardiovascular dis-
ease (CVD) was defined as one or more definite manifes-
tations of coronary heart disease or stroke.
The Center for Epidemiologic Studies Depression Scale
(CES-D)[32], which has been previously validated in Chi-
nese populations[33,34], was used to measure the pres-
ence of clinically relevant depressive symptoms. Using the
accepted cut-off point of 16 for the sum of scores, a CES-Page 2 of 11
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and a CES-D score ≥16 was defined as minor depres-
sion.[32] Following a physical examination, BMI levels
were measured and categorized as under weight (<18.5
kg/m2), normal weight (18.5 to <24.0 kg/m2) and over-
weight/obese (≥24.0 kg/m2).[35] Three measurements of
blood pressure were taken using an electronic blood pres-
sure monitor and the mean of the last two measurements
was used for analysis.
Laboratory methods
Overnight fasting blood samples were collected in tubes
containing liquid ethylenediaminetetraacetic acid
(EDTA), centrifuged at 4°C, and stored at -80°C until
analysis. Total cholesterol, high-density lipoprotein
(HDL) cholesterol, low-density lipoprotein (LDL) choles-
terol, triglycerides (TG), and glucose were measured enzy-
matically (Hitachi 7080, Japan). Plasma C-reactive
protein (CRP) was measured by a particle-enhanced
immunoturbidimetric assay (Ultrasensitive CRP kit,
Orion Diagnostica, Espoo, Finland). Plasma adiponectin
concentrations were measured by Luminex xMAP™ Tech-
nology (Linco Research Inc, St Charles, Mo). All proce-
dures followed the manufacture's instruction with quality
controls in the expected ranges for each assay. Human
Retinol Binding Protein 4 (RBP4) was measured by a
sandwich ELISA developed in-house.[36] Interleuikin 6
(IL-6) was measured with high-sensitivity enzyme-linked
immuno-sorbent assay (ELISA) (Quantikine HS IL-6
Immunoassay, R&D Systems, Inc., Minneapolis, Minne-
sota). Plasma adiponectin, resistin and active plasmino-
gen activator inhibitor-1 (PAI-1) concentrations were
measured by Luminex xMAPTM Technology (Linco
Research Inc, St Charles, Mo).[27] Fasting glucose was
measured enzymatically on an automatic analyzer
(Hitachi 7080, Japan). Fasting insulin was determined by
radioimmunoassay (Linco Research, MO). Index of insu-
lin resistance was calculated using updated homeostasis
model assessment methods (HOMA2-IR, using the
HOMA2 calculator, http://www.dtu.ox.ac.uk).[37]
Statistical analyses
We evaluated the distribution of sleep quality in the total
population and how it varied by gender, geographic
region and area of residence. Using a chi-square test, anal-
ysis of variance or Wilcoxon rank-sum test and univariate
analysis, we evaluated the associations between sleep
quality and potential associated factors (selected based on
previous literature or scientific knowledge). Factors that
significantly modified sleep quality or those that were
consistently reported as significant determinants in previ-
ous publications were selected to be included in multivar-
iate analysis applying an ordinal regression model.
Multivariate analysis was repeated stratifying by gender,
region and residence one at a time and by stratifying for
two of these factors simultaneously.
The associations between sleep quality and biomarkers of
cardio-metabolic disease were tested on the total popula-
tion and on a sub-sample of participants whom were free
from CVD and diabetes with parametric t-tests (after log-
arithmic transformation of the data to satisfy normality
assumptions) or non-parametric Wilcoxon rank-sum
tests.
Data management and statistical analyses were performed
with the SAS statistical package version 9.1 (SAS Institute,
Cary, NC). Statistical tests were two-sided and at a 5%
level of significance.
Results
Characteristics of the participants
The mean age of the study sample was 58.6 years (Table
1). More than half of the participants were women
(55.7%), 72% were non-smokers (94% women and 44%
men), 72% were non alcohol drinkers (90% women and
48% men), 92% were involved in moderate or high levels
of physical activity and 53% were overweight or obese.
Three percent of the participants reported taking sleeping
pills (4% women and 1% men), 42% reported taking a
nap (56% in Beijing, 29% in Shanghai), 68% reported
having 7–9 hours of daily sleep and 53% reported good
sleep quality (Table 1). Thirty two percent of participants
reported good/excellent self-rated health, 9% of partici-
pants suffered from depressive symptoms (15% in Beijing
and 4% in Shanghai), 14% had diabetes (19% in Beijing
and 9% in Shanghai), 10% had CVD (15% in Beijing and
6% in Shanghai), 42% had metabolic syndrome (50% in
Beijing and 35% in Shanghai), 14% had hyperlipidemia,
7% had pulmonary disease, 13% arthritis and 11% pros-
tatisim (Table 1).
Distribution of sleep quality
More than half of the study population (53%) reported
good sleep quality (Beijing 46% vs. Shanghai 60%,
women 47% vs. 61% men). Almost a third of the popula-
tion (31%) reported a 'common' level of sleep quality
(Beijing 34% vs. 27% Shanghai, women 33% vs. 28%
men) and the rest (16%) reported poor sleep quality
(19% Beijing vs. 13% Shanghai, women 20% vs. men
11%) (Table 1, data for gender difference not shown).
Eighty-eight percent of the participants who reported
good sleep quality reported seven or more hours of daily
sleep. In participants that reported poor sleep quality,
84% had fair, poor or very poor SRH. Three per cent of
those with good sleep quality reported depressive symp-
toms, compared to 27% of those who reported poor sleep
quality Additionally, higher prevalence of CVD (20% vs.Page 3 of 11
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Table 1: Characteristics of the study participants by region
Variable, N (%) Total Beijing Shanghai P-value
Female gender 1819 (55.71) 894 (54.91) 925 (56.51) 0.3599
Rural residence 1638 (50.17) 808 (49.63) 830 (50.70) 0.5405
Age, mean(std) 58.59 (6.01) 58.30 (5.95) 58.87 (6.06) 0.0072
Age category, years 0.0134
50≤ age <60 1845 (56.51) 955 (58.66) 890 (54.37)
60≤ age ≤70 1420 (43.49) 673 (41.34) 747 (45.63)
BMI, mean(std) 24.46 (3.59) 25.26 (3.65) 23.67 (3.35) <.0001
BMI category <.0001
Under weight 111 (3.40) 37 (2.27) 74 (4.52)
Normal 1411 (43.22) 570 (35.01) 841 (51.37)
Over weight/Obese 1743 (53.38) 1021 (62.71) 722 (44.11)
Currently married (YES, %) 2862 (87.66) 1407 (86.43) 1455 (88.88) 0.0328
Living alone (YES, %) 185 (5.67) 93 (5.72) 92 (5.62) 0.9056
Smoking <.0001
Current 910 (27.87) 508 (31.20) 402 (24.56)
Former 326 (9.98) 206 (12.65) 120 (7.33)
Never 2029 (62.14) 914 (56.14) 1115 (68.11)
Current alcohol drinker 930 (28.48) 602 (36.98) 328 (20.04) <.0001
Physical activity, level <.0001
Low 242 (7.41) 128 (7.86) 114 (6.96)
Moderate 1368 (41.90) 581 (35.69) 787 (48.08)
High 1655 (50.69) 919 (56.45) 736 (44.96)
Educational level, years in school <.0001
0–6 1348 (41.29) 562 (34.52) 786 (48.01)
7–9 1163 (35.62) 698 (42.87) 465 (28.41)
≥10 754 (23.09) 368 (22.60) 386 (23.58)
Medical insurance (YES, %) 2280 (70.05) 872 (53.83) 1408 (86.12) <.0001
Annual income, Yuan <.0001
<10000 903 (29.07) 396 (25.13) 507 (33.14)
10000–29999 1409 (45.36) 797 (50.57) 612 (40.00)
≥30000 794 (25.56) 383 (24.30) 411 (26.86)
Employment <.0001
Employed 778 (23.83) 386 (23.71) 392 (23.95)
Retired 1803 (55.22) 842 (51.72) 961 (58.70)
Unemployed/on welfare 684 (20.95) 400 (24.57) 284 (17.35)
Social activities (YES, %) 1661 (50.87) 848 (52.09) 813 (49.66) 0.1659
Self-rated health status (good, %) 1041 (31.90) 483 (29.69) 558 (34.11) 0.0067
Diabetes (YES, %) 446 (14.04) 292 (18.83) 154 (9.48) <.0001
Metabolic syndrome (YES, %) 1392 (42.63) 815 (50.06) 577 (35.25) <.0001
Hyperlipidemia (YES, %) 430 (13.78) 257 (17.11) 173 (10.69) <.0001
Cardiovascular disease (YES, %) 327 (10.24) 228 (14.53) 99 (6.10) <.0001
Pulmonary disease (YES, %) 238 (7.33) 118 (7.30) 120 (7.37) 0.9399
Arthritis (YES, %) 431 (13.41) 227 (14.29) 204 (12.55) 0.1458
Prostatism (YES, %) 150 (10.81) 77 (11.21) 73 (10.43) 0.6402
Depressive symptoms (YES, %) 307 (9.40) 241 (14.80) 66 (4.03) <.0001
Sleeping pills intake (YES, %) 97 (2.97) 59 (3.63) 38 (2.32) 0.0281
Having nap (YES, %) 1382 (42.33) 911 (55.96) 471 (28.77) <.0001
Sleep quality <.0001
Well 1736 (53.17) 757 (46.50) 979 (59.80)
Common 1001 (30.66) 558 (34.28) 443 (27.06)
Poor 528 (16.17) 313 (19.23) 215 (13.13)
Sleep quantity, total hours of sleep/day <.0001
<7 799 (24.47) 346 (21.25) 453 (27.67)
7–9 2208 (67.63) 1119 (68.73) 1089 (66.52)
>9 258 (7.90) 163 (10.01) 95 (5.80)
Abbreviations: SD, standard deviation; BMI, Body Mass Index; CI, Confidence interval.
*Data are given as frequency (percentage) unless otherwise indicated.
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Table 2: Characteristics of the study participants by quality of sleep
Variable, N (%) Total Well Common Poor P-value
Female gender 1819(55.71) 849(48.91) 603(60.24) 367(69.51) <.0001
Beijing region 1628(49.86) 757(43.61) 558(55.74) 313(59.28) <.0001
Rural residence 1638(50.17) 956(55.07) 420(41.96) 262(49.62) <.0001
Age, mean(std) 58.59 (6.01) 58.61 (6.05) 58.69(6.00) 58.34(5.90) 0.5617
Age category, years 0.2195
50≤ age <60 1845(56.51) 975(56.16) 554(55.34) 316(59.85)
60≤ age ≤70 1420(43.49) 761(43.84) 447(44.66) 212(40.15)
BMI, mean(std) 24.46 (3.59) 24.33 (3.50) 24.66(3.68) 24.53(3.66) 0.056
BMI category 0.1373
Under weight 111 (3.40) 61 (3.51) 27 (2.70) 23 (4.36)
Normal 1411(43.22) 776 (44.70) 423 (42.26) 212 (40.15)
Over weight/Obese 1743(53.38) 889 (51.79) 551 (55.04) 293 (55.49)
Currently married (YES, %) 2862(87.66) 1547(89.11) 858(85.71) 457(86.55) 0.0237
Living alone (YES, %) 185(5.67) 89(5.13) 63(6.29) 33(6.25) 0.3664
Smoking <.0001
Current 910(27.87) 550(31.68) 241(24.08) 119(22.54)
Former 326(9.98) 184(10.60) 98(9.79) 44(8.33)
Never 2029(62.14) 1002(57.72) 662(66.13) 365(69.13)
Current alcohol drinker 930(28.48) 524(30.18) 293(29.27) 113(21.40) 0.0004
Physical activity, level 0.0025
Low 242(7.41) 120(6.91) 74(7.39) 48(9.09)
Moderate 1368(41.90) 681(39.23) 455(45.45) 232(43.94)
High 1655(50.69) 935(53.86) 472(47.15) 248(46.97)
Educational level, years in school 0.0026
0–6 1348(41.29) 762(43.89) 366(36.56) 220(41.67)
7–9 1163(35.62) 599(34.50) 371(37.06) 193(36.55)
≥10 754(23.09) 375(21.60) 264(26.37) 115(21.78)
Medical insurance (YES, %) 2280(70.05) 1236(71.40) 711(71.24) 333(63.31) 0.0011
Annual income, Yuan 0.0116
<10000 903(29.07) 512(31.05) 239(24.82) 152(30.77)
10000–29999 1409(45.36) 718(43.54) 469(48.70) 222(44.94)
≥30000 794(25.56) 419(25.41) 255(26.48) 120(24.29)
Employment <.0001
Employed 778(23.83) 473(27.25) 207(20.68) 98(18.56)
Retired 1803(55.22) 905(52.13) 598(59.74) 300(56.82)
Unemployed/on welfare 684(20.95) 358(20.62) 196(19.58) 130(24.62)
Social activities (YES, %) 1661(50.87) 910(52.42) 508(50.75) 243(46.02) 0.0362
Self-rated health status (good, %) 1041(31.90) 754(43.46) 203(20.30) 84(15.91) <.0001
Diabetes (YES, %) 446(14.04) 211(12.48) 154(15.81) 81(15.85) 0.0255
Metabolic syndrome (YES, %) 1392(42.63) 694(39.98) 451(45.05) 247(46.78) 0.0038
Hyperlipidemia (YES, %) 430(13.78) 175(10.45) 169(17.81) 86(17.30) <.0001
Cardiovascular disease (YES, %) 327(10.24) 122(7.17) 103(10.59) 102(19.69) <.0001
Pulmonary disease (YES, %) 238(7.33) 111(6.43) 77(7.73) 50(9.52) 0.0501
Arthritis (YES, %) 431(13.41) 175(10.21) 144(14.69) 112(21.54) <.0001
Prostatism (YES, %) 150(10.81) 66(7.78) 55(14.36) 29(18.59) <.0001
Depressive symptoms (YES, %) 307(9.40) 49(2.82) 116(11.59) 142(26.89) <.0001
Sleeping pills intake (YES, %) 97(2.97) 12(0.69) 21(2.10) 64(12.12) <.0001
Having nap (YES, %) 1382(42.33) 739(42.57) 428(42.76) 215(40.72) 0.7131
Sleep quantity, total hours of sleep/day <.0001
<7 799(24.47) 209(12.04) 273(27.27) 317(60.04)
7–9 2208(67.63) 1348(77.65) 668(66.73) 192(36.36)
>9 258(7.90) 179(10.31) 60(5.99) 19(3.60)
Abbreviations: SD, standard deviation; BMI, Body Mass Index; CI, Confidence interval.
*Data are given as frequency (percentage) unless otherwise indicated.
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8%) was observed among those that reported poor sleep
quality compared to those with good sleep quality (Table
2).
Sleep quality: associated factors
Based on the results of the univariate analyses -and previ-
ous publications-, gender, region, residential status, BMI,
alcohol consumption and smoking, physical activity, edu-
cational level, marital status, medical insurance coverage,
social activity, SRH, diabetes, CVD, arthritis, prostatisim,
depressive symptoms and sleep quantity were chosen to
be analysed in the multivariate analysis (Table 3).
The results of the multivariate analysis indicated that gen-
der (Odds Ratio (OR) 0.51; 95% Confidence Interval (CI)
0.41 to 0.64), region (OR 0.61; 95% CI 0.51 to 0.73),
medical insurance coverage (OR 0.73; 95% CI 0.59 to
0.90), social activity (OR 0.80; 95% CI 0.69 to 0.94), res-
idential status (OR 1.27; 95% CI 1.01 to 1.60), SRH (OR
2.48; 95% CI 2.08 to 2.96), depressive symptoms (OR
4.05; 95% CI 3.12 to 5.26), CVD (OR 4.05; 95% CI 3.12
to 5.26) and sleep duration (<7 hours daily sleep (OR
0.10; 95% CI 0.07 to 0.14), 7–9 hours daily sleep (OR
0.58; 95% CI 0.42 to 0.78)) affected the quality of sleep
independently from the effect of other variables in the
model (Table 3).
When we stratified the analyses by region (Beijing/Shang-
hai) we found that gender, depressive symptoms, self-
rated health and sleep duration still remained signifi-
cantly associated with sleep quality in both north and
south China. Residential status, marital status, social
activity and present CVD only affected the sleep quality of
participants living in Shanghai, while arthritis only
affected those living in Beijing (Table 3).
Table 3: Adjusted associated factors of sleep quality for the total population and stratified by regional area of living
Association with sleep quality (OR with 95% CI)
Variable Total Beijing Shanghai
Gender (female vs. male) 0.51 (0.41–0.64)* 0.55 (0.40–0.75)* 0.50 (0.36–0.71)*
Residential location (rural vs. urban) 1.27 (1.01–1.60)* 1.08 (0.77–1.52) 1.66 (1.13–2.43)*
Geographic location
(Beijing vs. Shanghai)
0.61 (0.51–0.73)*
Body Mass Index (BMI)
normal vs. over weight 0.92 (0.79–1.07) 1.05 (0.84–1.30) 0.81 (0.65–1.01)
under weight vs. over weight 0.74 (0.49–1.12) 0.35 (0.17–0.72) 1.03 (0.60–1.76)
Smoking
current vs. never smoker 0.90 (0.71–1.14) 0.79 (0.58–1.08) 1.05 (0.72–1.55)
former vs. never smoker 0.98 (0.72–1.32) 1.15 (0.78–1.70) 0.69 (0.42–1.13)
Alcohol drinking (No vs. yes) 0.97 (0.80–1.18) 0.95 (0.74–1.23) 0.89 (0.65–1.22)
Physical activity
high vs. low 1.09 (0.81–1.46) 0.93 (0.62–1.39) 1.26 (0.81–1.95)
moderate vs. low 0.94 (0.70–1.28) 0.81 (0.53–1.23) 1.07 (0.68–1.68)
Educational level, years in school
group 1 vs. 3 1.24 (0.97–1.59) 1.38 (0.98–1.94) 0.91 (0.61–1.35)
group 2 vs. 3 1.06 (0.86–1.30) 1.13 (0.84–1.53) 0.93 (0.69–1.26)
Marital status
(no spouse vs. spouse)
1.25 (1.00–1.56)* 1.14 (0.84–1.55) 1.52 (1.07–2.15)*
Medical insurance (no vs. yes) 0.73 (0.59–0.90)* 0.84 (0.60–1.16) 0.77 (0.55–1.07)
Employment
employed vs. retired 1.05 (0.86–1.28) 1.07 (0.80–1.43) 0.96 (0.72–1.28)
unemployed vs. retired 1.00 (0.81–1.25) 0.80 (0.59–1.08) 1.30 (0.93–1.81)
Social activity (no vs. yes) 0.80 (0.69–0.94)* 0.83 (0.66–1.03) 0.80 (0.64–1.00)*
Self rated health status (good vs. not good) 2.48 (2.08–2.96)* 2.25 (1.76–2.88)* 2.63 (2.03–3.41)*
Diabetes (no vs. yes) 1.01 (0.82–1.26) 1.10 (0.84–1.44) 0.98 (0.68–1.41)
Cardiovascular disease (no vs. yes) 1.47 (1.15–1.88)* 1.25 (0.92–1.71) 2.14 (1.41–3.26)*
Arthritis (no vs. yes) 1.23 (0.99–1.53) 1.40 (1.04–1.89)* 1.11 (0.81–1.53)
Depressive Symptoms
(no vs. yes)
4.05 (3.12–5.26)* 3.91 (2.88–5.29)* 5.00 (2.94–8.52)*
Total hours of sleep/day * * *
<7 vs. 9< hrs 0.10 (0.07–0.14)* 0.10 (0.07–0.15)* 0.10 (0.05–0.17)*
7–9 vs. 9< hrs 0.58 (0.42–0.78)* 0.64 (0.44–0.92)* 0.53 (0.31–0.92)*
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; OR, Odds ratio; CI, Confidence interval. *P < 0.05.
Group 1, 2 and 3 for educational level are 0–6, 7–9 and ≥10 years in school respectively.Page 6 of 11
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taneously (Table 4), the effect of SRH, presence of depres-
sive symptoms and sleep duration remained significant
among all subgroups. Marital status, social activity, pros-
tatism and residential status significantly affected Shang-
hai men and CVD significantly affected Beijing men and
Shanghai women.
Sleep quality and cardio-metabolic biomarkers
Significant differences in the level of resistin, PAI-1, insu-
lin, HOMA-IR, HOMA2-IR, LDL, TCH and TG were
observed between different levels of sleep quality (Table
5). When we analyzed these associations among a sub-
sample of the population who were free from CVD and
diabetes, we found that significant associations remained
for insulin, HOMA-IR, HOMA2-IR, LDL, TCH and TG
(data not shown).
Discussion
Only half of middle aged and elderly Chinese in our study
reported good sleep quality. Quality of sleep varied sub-
stantially by gender and geographical location and was
affected by level of self-rated health, presence of depres-
sive symptoms, sleep quantity, chronic diseases and social
activity. Significant associations between levels of sleep
quality and resistin, PAI-1, insulin, HOMA-IR, HOMA2-
IR, LDL, TCH and TG were observed. These associations
remained significant for insulin, HOMA-IR, HOMA2-IR,
LDL and TCH among a subgroup of participants who were
free of CVD and diabetes.
Sixteen percent of the elderly Chinese assessed their sleep
quality as poor in this study. They showed higher preva-
lence of mental and physical diseases (depression, CVD,
arthritis, prostatism (men only)) and shorter daily sleep
time compared to participants that reported a good level
Table 4: Adjusted associated factors of sleep quality stratified by region and gender
Association with sleep quality (OR with 95% CI)
Variable Beijing-Male Shanghai-Male Beijing-Female Shanghai-Female
Residential location (rural vs. urban) 1.50 (0.92–2.45) 3.90 (2.06–7.39)* 0.68 (0.41–1.14) 0.86 (0.51–1.45)
Body Mass Index (BMI)
normal vs. over weight 1.03 (0.73–1.47) 0.77 (0.53–1.11) 0.98 (0.73–1.32) 0.79 (0.60–1.05)
under weight vs. over weight 0.21 (0.08–0.57)* 1.27 (0.47–3.48) 0.42 (0.14–1.28) 0.91 (0.46–1.79)
Smoking
current vs. never smoker 0.81 (0.52–1.27) 0.96 (0.62–1.48) 0.75 (0.47–1.22) 0.80 (0.24–2.66)
former vs. never smoker 1.16 (0.69–1.95) 0.63 (0.36–1.08) 1.06 (0.52–2.18) 0.17 (0.01–2.75)
Alcohol drinking (no vs. yes) 0.84 (0.59–1.19) 0.86 (0.58–1.26) 1.20 (0.81–1.77) 0.88 (0.44–1.75)
Physical activity
high vs. low 0.99 (0.50–1.98) 2.09 (1.02–4.30)* 0.77 (0.46–1.30) 0.98 (0.55–1.75)
moderate vs. low 0.70 (0.34–1.42) 1.57 (0.75–3.31) 0.77 (0.45–1.32) 0.83 (0.45–1.50)
Educational level, years in school ‡
group 1 vs. 3 1.70 (0.98–2.96) 0.74 (0.37–1.50) 1.26 (0.79–1.99) 0.91 (0.54–1.52)
group 2 vs. 3 1.05 (0.68–1.62) 0.82 (0.50–1.35) 1.18 (0.78–1.81) 0.82 (0.55–1.22)
Marital status
(no spouse vs. spouse)
1.12 (0.64–1.96) 4.87 (2.12–11.19)* 1.30 (0.89–1.89) 1.08 (0.72–1.62)
Medical insurance (no vs. yes) 0.67 (0.42–1.09) 0.75 (0.44–1.28) 1.06 (0.66–1.71) 0.75 (0.48–1.16)
Employment
employed vs. retired 0.82 (0.55–1.23) 1.10 (0.71–1.70) 1.34 (0.86–2.11) 0.93 (0.62–1.41)
unemployed vs. retired 0.77 (0.46–1.27) 1.29 (0.75–2.19) 0.96 (0.64–1.44) 1.68 (1.05–2.68)*
Social activity (no vs. yes) 0.86 (0.60–1.22) 0.64 (0.44–0.93)* 0.82 (0.61–1.10) 0.99 (0.74–1.33)
Self rated health status
(good vs. not good)
2.18 (1.51–3.16)* 3.11 (2.00–4.83)* 2.36 (1.68–3.31)* 2.43 (1.75–3.39)*
Diabetes (no vs. yes) 1.05 (0.68–1.61) 0.78 (0.45–1.34) 1.15 (0.80–1.65) 1.11 (0.66–1.86)
CVD (no vs. yes) 1.78 (1.12–2.83)* 1.58 (0.85–2.96) 0.82 (0.53–1.25) 2.72 (1.47–5.04)*
Arthritis (no vs. yes) 1.74 (0.96–3.15) 0.56 (0.29–1.09) 1.35 (0.94–1.94) 1.31 (0.89–1.93)
Prostatism (no vs. yes) 1.17 (0.69–1.99) 1.72 (1.00–2.97)*
Depressive Symptoms
(no vs. yes)
3.13 (1.82–5.38)* 9.06 (3.50–23.49)* 4.34 (2.95–6.36)* 3.44 (1.77–6.66)*
Total hours of sleep/day * * * *
<7 vs. 9< hrs 0.12 (0.06–0.23)* 0.11 (0.04–0.29)* 0.08 (0.04–0.14)* 0.08 (0.04–0.16)*
7–9 vs. 9< hrs 0.66 (0.37–1.16) 0.61 (0.23–1.62) 0.64 (0.39–1.06) 0.45 (0.22–0.90)*
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; CVD, Cardio-Vascular Disease; OR, Odds ratio; CI, Confidence interval. 
*P < 0.05.
‡ Group 1, 2 and 3 for educational level are 0–6, 7–9 and ≥10 years in school respectively.Page 7 of 11
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ferences in those who reported poor sleep quality wherein
Chinese women were almost 50% less likely to report
good sleep quality than men. Similar to our findings, Li et
al.[6] found a 12% prevalence of insomnia among Hong
Kong Chinese adults. Li et al.[6] studied 9851 Hong Kong
Chinese aged 18–65 years and found a 60% greater
chance of insomnia being reported among women than
men. Klink et al.[5] also found there was a 50% higher
chance of women reporting insomnia. Furthermore, in a
study of 400 adults aged 20–70 years, Reyner et al.[7]
found women, reported more awakenings, more total
time spent awake during the night and poorer sleep qual-
ity. This difference in sleep quality could be due to gender
differences in the prevalence of psychiatric morbidities,
socio-cultural factors and coping strategies. [5-7]
We also found that sleep quality related to geographical
location. Those living in the north were 40% less likely to
report good sleep quality compared to those living in the
south. This could be due to differences between the two
cities wherein compared to Shanghai residents, Beijing
residents show almost twice the prevalence of chronic dis-
eases (depression, CVD, diabetes and metabolic syn-
drome), higher levels of alcohol consumption (37%
Beijing vs. 20% Shanghai) and smoking (31% Beijing vs.
25% Shanghai), higher prevalence of nap taking (55%
Beijing vs. 29% Shanghai) and less medical insurance cov-
erage (53% Beijing vs. 86% Shanghai). To our knowledge
this is the first study investigating differences in sleep
quality as a function of geographical and residential status
in China.
The effect of SRH (which is considered to be a valid repre-
sentative of physical and mental health[38-40]) was sub-
stantial on sleep quality for the total population and for
gender and geographical subgroups. Those who reported
good/excellent SRH had twice the chance of reporting
good sleep quality compared to those that had fair, poor
or very poor SRH.
In our study, we also found a strong association between
sleep quality and presence of depressive symptoms, with
the strongest effect among Shanghai men and Beijing
women. The likelihood of reporting poor sleep quality
was three times higher in the presence of depressive symp-
toms. Our findings are consistent with other studies that
have shown significant associations between depression
and insomnia[41] and depression and sleep distur-
bances.[42] The association between poor sleep and
depression has also been observed in an elderly popula-
tion.[2]
Currently, the number of hours required for optimal func-
tioning in an elderly population is not known. Although
it is commonly believed that 8 hours of sleep per night is
optimal for good health, recent studies suggest that mor-
tality risk is lower among those sleeping 7 hours.[21] The
total hours of daily sleep includes night time sleep and
nap time (nap taking is common mainly in north of
China) and for that reason, 7–9 hours was categorized as
normal daily sleep hours in our study. We found a sub-
stantial effect of sleep quantity on quality of sleep. Having
a short sleep time significantly decreased the chance of
reporting good quality of sleep. Even those reporting 7–9
Table 5: Cardio-metabolic factors and biomarkers by levels of sleep quality
Variable, mean (SD) Total well common poor p-value
Resistin 11.47(9.37) 11.26 (8.92) 11.24 (8.92) 12.57 (11.34) 0.0428*
PAI-1 14.74(18.17) 14.35 (18.71) 15.44 (17.56) 14.71 (17.50) 0.0011*
RBP4 40.11(11.74) 39.78 (11.59) 40.48 (11.58) 40.47 (12.48) 0.2924
Adiponectin 16.48(11.62) 16.47 (11.58) 16.06 (11.41) 17.29 (12.11) 0.1914
IL-6 1.55(2.78) 1.46 (2.13) 1.68 (3.63) 1.61 (2.84) 0.4680
CRP 1.58(4.30) 1.42 (2.29) 1.72 (5.54) 1.82 (6.24) 0.9505
Insulin 15.46(9.50) 15.00 (9.37) 16.07 (8.86) 15.81 (10.93) <0.0001*
HOMA-IR 4.10(3.36) 3.95 (3.36) 4.32 (3.25) 4.14 (3.55) <0.0001*
HOMA2-IR 0.31(0.22) 0.29 (0.19) 0.32 (0.27) 0.31 (0.22) <0.0001*
SBP 140.11(22.49) 139.5 (22.06) 140.7 (22.94) 141.1 (22.99) 0.2338
DBP 80.16(10.79) 80.18 (10.74) 80.15 (10.82) 80.11 (10.92) 0.9892
HDL 1.28(0.33) 1.27 (0.33) 1.27 (0.33) 1.30 (0.36) 0.5415
LDL 3.26(0.97) 3.19 (0.94) 3.36 (0.99) 3.30 (1.01) <0.0001*
TCH 4.70(0.98) 4.63 (0.97) 4.79 (0.97) 4.75 (1.02) 0.0001*
TG 1.39(1.07) 1.36 (1.07) 1.44 (1.12) 1.39 (0.96) 0.0490*
Abbreviations: PAI-1, plasminogen activator inhibitor-1; RBP4, retinol binding protein 4; IL-6, interleukin-6; IL6, interleukin-6; CRP, C-reactive 
protein; HOMA-IR, homeostasis model assessment of insulin resistance (fasting glucose (mmol/L) × fasting insulin (μU/ml)/22.5); SBP, systolic blood 
pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TCH, total cholesterol; TG, triglycerides; SD, 
standard deviation;Page 8 of 11
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quality than those reporting more than 9 hours of daily
sleep. Presence of CVD also affected the levels of sleep
quality among the total population but when we stratified
by gender and residential location this effect remained sig-
nificant only among Beijing men and Shanghai women.
We did not find any significant association between sleep
quality and different lifestyle characteristics (smoking and
alcohol drinking habits), age and BMI. This is consistent
with Elwood et al. [38] who studied 1986 welsh men aged
55–69 y and found no significant association between
prevalence of insomnia and age, BMI, smoking and alco-
hol drinking habits. However, it is possible that the effect
of smoking and alcohol drinking in our analysis might be
confounded with gender as the majority of Chinese smok-
ers and drinkers were men. Furthermore, this is affected by
the limited number of participants in the extreme catego-
ries of alcohol consumption and BMI, which limits the
statistical power to identify a potential association
between these two variables and sleep patterns in our
population.
Despite lower socio-economic status (lower average
income, fewer years in full-time education and less medi-
cal insurance coverage) rural residents were more likely to
report good levels of sleep quality compare to urban resi-
dents. This could be due to differences in lifestyle wherein
those who live in rural areas tend to have higher levels of
physical activity, higher age of retirement, less stressful
lifestyles and a lower prevalence of both CVD (7.7% rural
vs. 13% urban) and diabetes (11.4% rural vs. 17% urban).
In our analyses of the total sample and subgroups of the
sample, we found no significant effects of income and
education. This could be due to the fact that residence is a
more comprehensive factor that might partially confound
the effect of socio-economic factors (i.e. our sample of the
Chinese population is skewed towards lower income and
education and late retirement in rural areas).
Concentrations of inflammatory biomarkers, plasma
insulin and index of insulin resistance were associated
with sleep quality for the total population and among a
subgroup of participants that were free from CVD and dia-
betes. However, no clear trends in the levels of biomarkers
as a function of the different levels of sleep quality (good/
common/poor) were observed. This is the first study to
evaluate the associations between sleep quality and
inflammatory markers and measures of insulin resistance
in China and to evaluate the distribution and factors asso-
ciated with sleep quality in such a vast country which has
many geographical and residential differences
Although we considered the effect of comprehensive
measurements of lifestyle, socio-demographic factors and
presence of disease, our findings were limited. This could
be due to the cross-sectional nature of our data and fur-
ther longitudinal studies should be carried out to confirm
our findings.
Furthermore, sleep patterns were measured using a ques-
tionnaire; a criticism of this type of measurement is that
answers are provided by the participants and can be
affected by recall bias. Furthermore, due to the size of the
population and the extent of the general questionnaire,
for logistic reasons the questions that we used are not as
thorough as alternative validated questionnaires designed
to evaluate sleep disturbances (e.g The Pittsburg Sleep
Quality Inventory). Nevertheless, these factors could only
generate a non-differential misclassification of the expo-
sure (sleep patterns) that would attenuate the size of the
effects hereby reported and the level of sleep disturbances
in the population studied, but not necessarily our results
and conclusions. Prospective evaluations and studies that
provide more sensitive measures of sleep patterns in Chi-
nese populations are required to clarify the determinants
that affect sleep quality. This will also allow us to assess
whether sleep disturbances are associated with early devi-
ations from adequate cardio-metabolic health.
Conclusion
In general, only half of the population reported good
sleep quality. Compared to their counterparts, men and
people living in south China were twice as likely to report
good sleep quality. Both physical and mental health sig-
nificantly affected the quality of sleep in elderly Chinese
and having enough daily sleep hours substantially
increased the likelihood of reporting better sleep quality.
Although we did not find any clear trends between levels
of sleep quality and levels of inflammatory markers, we
did find a significant association between levels of sleep
quality and resistin, insulin, HOMA-IR, HOMA2-IR, LDL,
and TCH. These associations were found among the total
population and a subgroup of participants free from CVD
and diabetes.
Considering the alarming increase of sleep disturbances
that modern societies are experiencing and the deleterious
consequences that a poor night sleep can exert on our
metabolism and health, it is fundamental to clarify the
factors that might generate sleep disturbances, how these
disturbances can affect the biological homeostasis and
identify potential interventions to prevent sleep distur-
bances at an early stage.
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